14 papers
Time restricted
14 publications — 6 trials, 5 syntheses.
Hvad denne side er bygget på, emne for emne: hvor mange artikler, hvor mange er forsøg, og hvor nylige. Genereret fra indsamlingen, så det ikke kan afvige fra selve citaterne.
14 papers
14 publications — 6 trials, 5 syntheses.
13 papers
13 publications — 3 trials, 7 syntheses.
12 papers
12 publications — 4 trials, 4 syntheses.
10 papers
10 publications — 2 trials, 6 syntheses.
10 papers
10 publications — 3 trials, 6 syntheses.
9 papers
9 publications — 3 trials, 5 syntheses.
9 papers
9 publications — 5 trials, 1 synthesis.
8 papers
8 publications — 3 trials, 3 syntheses.
7 papers
7 publications — 1 trial, 5 syntheses.
What the trials actually show about semaglutide, tirzepatide and the rest of the GLP-1 class.
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep, circadian rhythm and the wearables that claim to measure both.
Denne side blev automatisk oversat fra engelsk. Citaterne og tallene er uændrede. Læs den engelske original, hvis noget lyder underligt. Læs den engelske original